SCHEMBL24554531

SCHEMBL24554531

CNCCCN(C)c1ccc(/N=N/c2cc(OC)c(/N=N/c3ccc([N+](=O)[O-])cc3)cc2OC)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP14 P50281 1/20 0.55
▸ MAPT P10636 6/20 0.48
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ TNNI3 P19429 1/20 0.40
▸ TNNT2 P45379 1/20 0.40
▸ TNNC1 P63316 1/20 0.40
▸ KEAP1 Q14145 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CDC25C P30307 3/20 0.39
▸ THRB P10828 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19456492 0.88 MMP14 (0.56) MMP14MAPTALDH1A1POLBGAA
SCHEMBL20588507 0.87 MMP14 (0.54) MMP14MAPTALDH1A1POLBGAA
SCHEMBL20588505 0.87 MMP14 (0.54) MMP14MAPTALDH1A1POLBGAA
SCHEMBL2002779 0.86 MMP14 (0.78) MMP14MAPTALDH1A1POLBGAA
SCHEMBL13401334 0.86 MMP14 (0.78) MMP14MAPTALDH1A1POLBGAA
SCHEMBL31672216 0.86 MMP14 (0.78) MMP14MAPTALDH1A1POLBGAA
SCHEMBL17766830 0.83 MMP14 (0.56) MMP14MAPTALDH1A1POLBGAA
SCHEMBL16377653 0.83 MMP14 (0.56) MMP14MAPTALDH1A1POLBGAA
SCHEMBL25712978 0.83 MMP14 (0.61) MMP14MAPTALDH1A1POLBGAA
SCHEMBL18025268 0.82 MAPT (0.49) MMP14MAPTALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220195500-A1 PROBES FOR DETECTING RNA AND METHODS OF USE THEREOF VANDERBILT UNIVERSITY 2022-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220195500-A1 PROBES FOR DETECTING RNA AND METHODS OF USE THEREOF RNGTT, NSUN3, NSUN2 MMP14 1433/4885MAPT 4550/4885ALDH1A1 2554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback